Related Experiment Video
Updated: Jun 18, 2026

10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Cardiac contractility during hemofiltration in an awake model of hyperdynamic endotoxemia
Satoshi Ishihara1, John A Ward, Osamu Tasaki
1Department of Acute Medicine (S.I.), Kawasaki Medical School, Okayama, Japan. ishihara@med.kawasaki-m.ac.jp
The Journal of Trauma
|November 11, 2009
Summary
Continuous veno-venous hemofiltration maintained left ventricular (LV) contractility and improved cardiac output in a swine model of endotoxemia. Hemofiltration prevented LV impairment during sepsis.
Area of Science:
- Critical Care Medicine
- Cardiovascular Physiology
- Renal Replacement Therapy
Background:
- Hyperdynamic endotoxemia in swine models human sepsis.
- Endotoxemia causes hemodynamic instability and left ventricular (LV) dysfunction.
- Circulating plasma mediators contribute to sepsis-induced myocardial depression.
Purpose of the Study:
- To investigate if continuous veno-venous hemofiltration (CVVH) can mitigate hemodynamic instability and LV dysfunction.
- To assess the effect of CVVH on circulating plasma mediators in endotoxemia.
- To evaluate LV contractility using LV end-systolic elastance (Ees) as an index.
Main Methods:
- Nineteen swine were randomly assigned to control (CTRL), hemofiltration (HF), or extracorporeal circuit (ECC) groups.
- All animals received intravenous E. coli endotoxin and resuscitation for 24 hours.
- CVVH was initiated 30 minutes after endotoxin infusion.
Main Results:
- LV end-systolic elastance (Ees), an index of contractility, was preserved in the HF group but decreased in CTRL and ECC groups.
- Cardiac output was significantly higher in the HF group compared to the CTRL group.
- Plasma catecholamine levels did not differ significantly between groups.
Conclusions:
- Continuous veno-venous hemofiltration effectively prevented left ventricular (LV) impairment during experimental endotoxemia.
- CVVH may be a beneficial intervention for managing sepsis-induced cardiac dysfunction.
- Reducing circulating mediators via hemofiltration may preserve myocardial function.
